Commercial Space Company Risk / Opportunity Ranking

Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence survived the 90-day recent evidence window.

Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent.

Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent.

Thesis: The reviewed sources offers only relation-style context and no direct positive evidence, so there is no supportable opportunity thesis.

Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided.

Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources.

Thesis: The reviewed sources indicates membership support that Canada Rocket Company was identified as one of three Canadian rocket startups receiving government funding, but no within the recent evidence window direct positive evidence or article summaries are available for scoring, so opportunity evidence is too thin to form a positive thesis from these reviewed sources alone.

Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen.

Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence.

Thesis: The reviewed sources contain no direct positive evidence for Canon within the scoring window. The membership rationale says Canon is mentioned only as one of Rocket Lab's partners/customers in a CubeSat article, which is too incidental to support a company-level opportunity thesis.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe.

Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context.

Thesis: This reviewed sources slice references only competitive landscape and generic market-report mentions in the phase-2 rationale, with no retained direct positive evidence in the recent evidence window, so there is not enough support for a positive thesis.

Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent.

Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used.

Thesis: The only possible positive read is from the phase2 rationale, which says Casimir raised a $12M seed round and is tied to a NASA-veteran founder. If accurate, recent financing could support development over a 1 year+ horizon, but the reviewed sources does not include a citable article /summary and also notes the business described is quantum vacuum energy chips rather than a clearly defined target space operating category.

Why now: There is no available article summary or evidence row after recent evidence window, so the only 'why now' is the uncitable phase2 statement about a seed round referenced by article id: without.

Caveats: The reviewed sources itself says the support article is blog commentary, weakening source quality. No citable or summary is provided for the referenced article id No evidence were available after recent evidence window in the served reviewed sources.

Thesis: The reviewed sources does not load any direct positive evidence within the 90-day recent evidence window, so no positive thesis is supported.

Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources.

Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

Thesis: The reviewed sources does not retain sufficient direct positive evidence for a durable opportunity thesis.

Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window.

Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available.

Thesis: The reviewed sources only says an opinion piece listed China Spacesat among global space companies, with no direct facts or events specific to the company retained after recent evidence window, so there is no evidence basis for a positive thesis.

Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window.

Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence.

Thesis: No positive thesis is supportable from the retained reviewed sources evidence because there is no direct positive evidence after recent evidence window.

Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided.

Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company.

Thesis: The reviewed sources only indicates that Clear Space develops space lidars in a space or aerospace context. That is not enough to support a meaningful positive thesis over a 1 year+ horizon without current financing, contracts, or milestone evidence.

Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources.

Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed.

Thesis: The reviewed sources notes many mentions tied mainly to RTX/Raytheon and market lists, but does not cleanly establish 'Collins' as a target company with direct positive business evidence in the recent evidence window.

Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or.

Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered.

Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence or representative article summaries are provided within the recent evidence window.

Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources.

Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields.

Thesis: The reviewed sources rationale weakly suggests possible opportunity because Cosmoserve is mentioned among Indian space-tech startups and the article notes product-technologies including satellite communications. But the reviewed sources does not directly describe Cosmoserve's own business or provide a citable article summary/ in the recent evidence window.

Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing.

Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window.

Thesis: The company is described in membership rationale as participating in debris removal and RPOD-related activity, but no retained 90-day direct positive evidence supports a forward opportunity thesis.

Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update.

Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears.

Thesis: The membership rationale suggests funding and space situational awareness relevance, but the served reviewed sources retains no 90-day positive evidence to support a long-horizon opportunity thesis.

Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data.

Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment.

Thesis: The reviewed sources indicates Digantara is relevant to space situational awareness and references a missile tracking satellite, which could imply strategic relevance, but there is no usable in-window article or evidence available for directional scoring.

Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing.

Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources.

Thesis: Only a minimal opportunity view is possible because the phase2 rationale says DPhi Space was using Solstar's Deke system and was identified as Swiss, implying some active space-company involvement. But the reviewed sources explicitly says the business fit remains indirect and thin.

Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst.

Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window.

Thesis: The reviewed sources membership rationale says EarthDaily received an NRO contract for EO/IR under Strategic Commercial Enhancements, which could support a long-horizon government-demand opportunity, but no within the recent evidence window evidence or article details were available to substantiate the claim for ranking use in this screen.

Why now: Why now is weak because the reviewed sources show zero evidence kept within the 90-day recent evidence window for ranking, making recency and business-state assessment uncertain.

Caveats: Phase-2 membership rationale references: but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Cannot treat cohort membership as thesis attractiveness.

Thesis: Despite broad defense and space-adjacent relevance in the membership rationale, the reviewed sources have no direct positive evidence within the recent evidence window, so no positive 1 year+ thesis is supportable.

Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources.

Thesis: No negative thesis can be established because no direct negative evidence for Apparition Geoservices GmbH is available in the reviewed sources after recent evidence filtering.

Why now: No current business-state change or catalyst is visible. Although 6 articles were considered, coverage debug shows 0 articles after recent evidence window and 0 evidence after recent evidence window, while the membership review says the reviewed sources are only a broad European tech funding roundup without a direct company-specific description.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Mention count and article count do not increase conviction because no post-recent evidence window evidence are available. Review-status rationale says retrieval context is insufficient for membership.

Thesis: No negative thesis is supported because Arkeon has no direct negative evidence in the reviewed sources within the selected recent evidence window.

Why now: No company-specific timing signal is visible. Coverage debug shows zero post-recent evidence window articles and evidence, and the membership note says only a generic funding-roundup article was available without a company-specific description tying Arkeon to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct event, fact, or negative development is available after recent evidence window. Low membership confidence is not directional evidence.

Thesis: No negative thesis can be formed because the reviewed sources includes no direct negative evidence for Ars Magna Semiconductors within the recent evidence window.

Why now: There is no visible long-horizon strategic catalyst in the usable evidence. Coverage debug shows zero post-recent evidence window articles and evidence, and the only cited support is a general tech funding roundup without a company-specific description linking the company to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct positive or adverse operating evidence is available. Generic roundup context is weaker than company-specific evidence and is not directional proof.

Thesis: No negative thesis is supportable because the reviewed sources have no direct negative evidence for Augusta Labs after recent evidence filtering.

Why now: No current or durable catalyst can be identified from the reviewed sources. Coverage debug shows zero post-recent evidence window articles and evidence, and the membership note says the company is only present in a generic funding-roundup article without direct identification against the listed criteria.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Absence of risk evidence is not positive evidence. No direct company-specific facts or events are available.

Thesis: No negative thesis can be justified because no direct negative evidence for BeatpulseLabs is present in the reviewed sources within the recent evidence window.

Why now: There is no visible catalyst or deterioration signal. Coverage debug shows zero post-recent evidence window articles and evidence, and the only cited support is a generic funding-roundup article with no direct company-specific connection to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct event or fact evidence is available after recent evidence window. Generic context should not be treated as directional proof.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Bose Corporation after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 97 articles considered but 0 articles after recent evidence window and 0 evidence available after dedupe; despite broad article consideration, nothing survived the time/evidence filters for a 1 year+ thesis judgment.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Breaking Change after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 3 articles considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says the reviewed sources gives no meaningful company-specific evidence and references: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative thesis can be supported because there is no direct negative evidence for CameraMatics in the reviewed sources after recent evidence filtering.

Why now: No company-specific catalyst is visible despite 6 articles considered, because coverage debug shows 0 articles after recent evidence window and 0 evidence after recent evidence window. The membership note says the reviewed sources only includes CameraMatics in a generic funding roundup with no direct statement tying it to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Article count does not create conviction because no post-recent evidence window evidence are available. No direct positive or adverse company-specific event is available.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Camphouse after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic roundup mention was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Capsa AI after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for CardNexus after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says the reviewed sources does not provide direct company-specific evidence and references: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for CeQur after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no adverse events or facts are retained after recent evidence window.

Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article, but the reviewed sources does not include the article summary or retained evidence. Supplier relevance to the space ecosystem does not by itself justify an opportunity score without current retained evidence. Recency is uncertain because the supporting substantive claims are not preserved in the recent evidence window evidence set.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no adverse direct evidence remains after recent evidence window.

Why now: There is no current why-now signal in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article: but the actual retained evidence is absent from these reviewed sources. The rationale itself frames IHI more as a beneficiary/customer than clearly as the core space operator, which weakens directional use even if the older article were available.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because there are no direct negative evidence and no articles retained after the 90-day recent evidence window.

Why now: There is no current why-now signal in the reviewed evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after dedupe/recent evidence window.

Caveats: Phase-2 rationale references article: but that article content is not provided here and no retained evidence remain after recent evidence window. Membership review status is not directional proof. Absence of evidence should not be interpreted as absence of business activity.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no adverse evidence remains after the 90-day recent evidence window.

Why now: No current why-now signal is available in the retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite substantial historical article count.

Caveats: Phase-2 rationale references articles: and: but their content is not included here. Historical mention density is not conviction. Public listing/ticker presence does not create a directional thesis without retained evidence.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no negative events or facts are retained after recent evidence window.

Why now: No current why-now signal is available in the retained evidence. Coverage debug shows zero articles after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article: but the underlying article details are not included here. A referenced letter of intent, without retained evidence details or timing, is insufficient for a 1 year+ directional ranking. Private-company status may limit visibility, but that is not itself a thesis.

Thesis: No negative thesis can be supported from the reviewed sources because there is no direct negative evidence available for Zone14 within the 90-day recent evidence window.

Why now: There is no current company-specific catalyst visible in the reviewed sources. Coverage debug shows zero articles after recent evidence window and zero evidence after recent evidence window for Zone14; the membership note says it appears only through a broad funding roundup and lacks company-specific evidence tied to the listed scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. Company appears only in review status with low membership confidence, which is not directional evidence.